(Q37928143)

25 August 2017

1 reference

title

The safety profile of quinapril: is there a difference among ACE inhibitors? (English)

1 reference

25 August 2017

Canter D

1

1 reference

25 August 2017

Frank GJ

series ordinal

2

1 reference

25 August 2017

Knapp LE

series ordinal

3

1 reference

25 August 2017

McLain RW

series ordinal

4

1 reference

25 August 2017

publication date

1 June 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

6 Suppl 7

1 reference

25 August 2017

page(s)

VII39-42

1 reference

Comparison of captopril and enalapril in patients with severe chronic heart failure

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960131408

7 January 2021

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960131408

7 January 2021

Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960131408

7 January 2021

Overall tolerance and safety of quinapril in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960131408

7 January 2021

The safety of ACE inhibitors for the treatment of hypertension and congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960131408

7 January 2021

Angiotensin-converting enzyme inhibitors: past, present, and bright future

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960131408

7 January 2021

The clinical pharmacokinetics of quinapril

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960131408

7 January 2021

Identifiers

DOI

10.1002/CLC.4960131408

0 references

1 reference